Augier Eric, Dulman Russell S, Singley Erick, Heilig Markus
Center for Social and Affective Neuroscience, IKE, Linköping University;
Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health.
J Vis Exp. 2017 Jan 29(119):53305. doi: 10.3791/53305.
Operant oral self-administration methods are commonly used to study the reinforcing properties of ethanol in animals. However, the standard methods require saccharin/sucrose fading, water deprivation and/or extended training to initiate operant responding in rats. This paper describes a novel and efficient method to quickly initiate operant responding for ethanol that is convenient for experimenters and does not require water deprivation or saccharin/sucrose fading, thus eliminating the potential confound of using sweeteners in ethanol operant self-administration studies. With this method, Wistar rats typically acquire and maintain self-administration of a 20% ethanol solution in less than two weeks of training. Furthermore, blood ethanol concentrations and rewards are positively correlated for a 30 min self-administration session. Moreover, naltrexone, an FDA-approved medication for alcohol dependence that has been shown to suppress ethanol self-administration in rodents, dose-dependently decreases alcohol intake and motivation to consume alcohol for rats self-administering 20% ethanol, thus validating the use of this new method to study the reinforcing properties of alcohol in rats.
操作性口腔自我给药方法常用于研究动物体内乙醇的强化特性。然而,标准方法需要糖精/蔗糖消退、禁水和/或长时间训练才能在大鼠中引发操作性反应。本文描述了一种新颖且高效的方法,可快速引发对乙醇的操作性反应,对实验者来说很方便,且不需要禁水或糖精/蔗糖消退,从而消除了在乙醇操作性自我给药研究中使用甜味剂的潜在混淆因素。使用这种方法,Wistar大鼠通常在不到两周的训练时间内就能习得并维持对20%乙醇溶液的自我给药行为。此外,在30分钟的自我给药过程中,血液乙醇浓度与奖励呈正相关。此外,纳曲酮是一种经美国食品药品监督管理局批准用于治疗酒精依赖的药物,已被证明可抑制啮齿动物的乙醇自我给药,它能剂量依赖性地减少自行摄入20%乙醇的大鼠的酒精摄入量和饮酒动机,从而验证了使用这种新方法来研究大鼠体内酒精的强化特性。